Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many patients begin GLP-1 therapy expecting rapid weight loss at the starting dose of 0.5mg semaglutide, but the reality is more nuanced. Clinical data shows that therapeutic dosing typically ranges from 1.0mg to 2.4mg weekly, meaning your initial prescription is intentionally conservative to build tolerance. If you've plateaued or stalled on 0.5mg, you're not alone—and the solution may involve understanding your individual peptide response.

The Starting Dose Is Rarely the Therapeutic Dose

Wegovy's 0.5mg initial dose serves one purpose: helping your body adapt to GLP-1 stimulation while monitoring tolerability. This dose typically suppresses appetite and slows gastric emptying, but it may not be potent enough to trigger significant weight loss in many patients. Clinical trials for semaglutide show that meaningful, sustained weight reduction accelerates once patients reach maintenance doses of 1.7mg to 2.4mg weekly—doses three to five times higher than where you started.

The problem many patients face is confusing tolerance with efficacy. You might feel less hungry on 0.5mg, experience mild nausea, or lose a few pounds in the first two weeks. However, these early changes reflect your body adjusting to the medication, not your maximum weight loss potential. After 4 to 8 weeks at the starter dose, many patients plateau because their system has adapted and the dose is no longer triggering the metabolic changes needed for continued fat loss.

Your Genetics May Be Limiting Your Response to Semaglutide

Not every body responds equally to the same GLP-1 receptor agonist. Genetic variation in your GLP1R gene (particularly the rs6923761 variant) influences how efficiently your cells bind and respond to semaglutide. Some patients have genetic predispositions that reduce GLP-1 receptor sensitivity, meaning they require higher doses or may benefit more from dual-agonist compounds like tirzepatide that activate additional pathways. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and identifies key variants like GLP1R, GIPR, FTO, and MC4R to predict individual compound efficacy before you waste time on a suboptimal therapy.

If genetic testing reveals reduced GLP-1 pathway responsiveness, switching to tirzepatide—which targets both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors—may unlock the weight loss you've been missing. This is why personalized medicine matters: your neighbor's rapid success on semaglutide doesn't mean semaglutide is your ideal choice.

Dose Escalation Is Normal and Expected in GLP-1 Therapy

If you've been on Wegovy 0.5mg for more than two months without meaningful weight loss, dose escalation is the standard next step. The Wegovy protocol involves increasing by 0.25mg every four weeks until reaching 2.4mg or until you hit your optimal dose. Stalling at 0.5mg means you haven't yet reached your therapeutic window. At PlexusDx, the approach is straightforward: your dose may need to go up. Your price won't. Compounded semaglutide injections start at $149 per month flat, regardless of whether you're taking 0.5mg or 2.4mg weekly.

Common escalation milestones include 1.0mg (mild appetite suppression), 1.7mg (moderate weight loss acceleration), and 2.4mg (maximum therapeutic effect for most patients). Some patients need to go even higher, while others find their sweet spot earlier. The key is systematic titration with honest tracking of hunger, fullness, nausea, and actual weight change every two to three weeks.

Lifestyle Factors That Block Weight Loss on GLP-1

Even at optimal doses, GLP-1 agonists work best within a framework of basic nutrition and movement. Patients who lose the most weight combine medication with a protein-forward diet (aiming for 25–35 grams of protein per meal) and 150+ minutes of weekly activity. If you're on 0.5mg and eating 3,000+ calories daily or living a sedentary lifestyle, the medication is fighting an uphill battle. GLP-1 drugs are powerful metabolic tools, but they're not magic replacements for fundamental lifestyle consistency.

Additionally, rapid weight loss on any GLP-1 therapy can trigger metabolic adaptation after 12–16 weeks, where your body's calorie-burning rate naturally decreases. If you're also experiencing increased hunger or fatigue, these are signals that your dose may be too low, your caloric deficit is unsustainable, or you need structured nutrition coaching to break the plateau.

When to Switch Medications or Seek Personalized Testing

If you've titrated to 1.7mg semaglutide over 8–12 weeks and still aren't losing weight at the rate you expected, three options emerge: continue escalating to 2.4mg, switch to tirzepatide (which activates an additional peptide pathway), or pursue genetic testing to understand your unique metabolic fingerprint. PlexusDx offers both paths: oral and injectable semaglutide (starting at $149/mo for injections), compounded tirzepatide (starting at $249/mo), or the dual-agonist GLP-Squared (starting at $249/mo for injections). After your first month on any therapy, the Precision Peptide Genetic Test ($99 add-on) reveals which of the 150+ genetic insights apply to your peptide response.

Switching medications isn't failure—it's data-driven optimization. A patient who doesn't respond to semaglutide monotherapy may see dramatic results on tirzepatide because their GIPR variant gives them superior GIP-pathway activation. This is why PlexusDx serves all 50 states with no insurance required and HSA/FSA eligibility: removing access barriers means you can find your ideal therapy faster, whether that's dose escalation or a completely different compound.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long should I stay on Wegovy 0.5mg before increasing the dose?

The standard escalation protocol recommends 4 weeks at each dose level, moving up by 0.25mg increments. If you're not seeing weight loss after 8 weeks on 0.5mg, discuss dose increase with your provider. Most therapeutic benefit occurs at 1.7mg or higher.

Can genetics explain why I'm not losing weight on semaglutide?

Yes. Variants in your GLP1R, GIPR, FTO, and MC4R genes influence how your body responds to specific GLP-1 drugs. PlexusDx Precision Peptide Genetic Test identifies these pathways and can reveal whether tirzepatide or a dual-agonist compound would be more effective for your genetic profile.

Is compounded semaglutide as effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and works identically to Wegovy. PlexusDx sources all compounds from accredited 503A facilities and offers the same dose escalation—starting at $149/mo—with no flat per-compound pricing increases.

What if I've maxed out semaglutide but still haven't hit my weight loss goal?

Switching to tirzepatide (a dual GLP-1/GIP agonist) activates an additional metabolic pathway and often produces faster results in semaglutide-plateau patients. PlexusDx offers compounded tirzepatide injections starting at $249/mo, with the same flat pricing structure.

Do I need insurance or a membership to access PlexusDx medications?

No. PlexusDx serves all 50 states without requiring insurance, memberships, or hidden fees. Medications are HSA/FSA eligible, and the Precision Peptide Genetic Test costs just $99 after your first month, giving you personalized insights into your peptide-response pathways.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves